Pulmatrix (PULM) Accumulated Expenses (2014 - 2026)
Pulmatrix (PULM) posted Accumulated Expenses of $254000.0 for Q1 2026, up 345.61% sequentially from $57000.0 in Q4 2025, and up 3.25% YoY from $246000.0 in Q1 2025.
Pulmatrix (PULM) Accumulated Expenses (2014 - 2026) Analysis & Trends
Pulmatrix has reported Accumulated Expenses for 13 years, with the latest figure at $254000.0 in Q1 2026.
- Quarterly Accumulated Expenses rose 3.25% year-over-year to $254000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $254000.0 (up 3.25% YoY) and the FY2025 annual result came in at $57000.0, up 50.0% from the prior year.
- Accumulated Expenses grew to $254000.0 in Q1 2026 per PULM's latest filing, from $57000.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $2.7 million in Q3 2022 and troughed at $38000.0 in Q4 2024.
- A 5-year average of $739882.4 and a median of $347000.0 in 2023 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses surged 2567.96% in 2022, then tumbled 90.8% in 2025.
- Over 5 years, Accumulated Expenses stood at $1.6 million in 2022, then sank by 78.82% to $347000.0 in 2023, then plunged by 89.05% to $38000.0 in 2024, then jumped by 50.0% to $57000.0 in 2025, then soared by 345.61% to $254000.0 in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $254000.0, $57000.0, and $180000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 160,000.00 |
| Mar 31, 2026 | 254,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 164,000.00 |
| Mar 31, 2025 | 246,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 578,000.00 |
| Dec 31, 2023 | 347,000.00 |
| Sep 30, 2023 | 704,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 523,000.00 |
| Dec 31, 2022 | 1.64 Mn |
| Sep 30, 2022 | 2.75 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 290,000.00 |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 103,000.00 |